AEGEA Medical

AEGEA Medical is pioneering the application of its Adaptive Vapor Ablation technology to deliver therapies that provide high quality patient outcomes to a wider range of patients. AEGEA’s FDA approved water vapor technology enables the delivery of a safe and effective endometrial ablation for the treatment of menorrhagia in a simple, office-based procedure that takes only minutes. With a vision to expand safe and effective treatment options to more patients, and provide physicians with the confidence and convenience necessary to perform office-based procedures, AEGEA is inspiring new approaches to women’s healthcare. Founded in 2008, AEGEA Medical is located in in Menlo Park, California.

AEGEA Medical headquartered in United States, North America, operates in the Biotechnology, Health Care, Manufacturing, Medical Device sector. The company focuses on Biotechnology and has secured $11.0B in funding across 96 round(s). With a team of 1-10 employees, AEGEA Medical is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - AEGEA Medical, raised $13.4M. Discover more about their projects, partnerships, and impact on our platform.